Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, ketamine and depression
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
What to Know About the New Nasal Spray for Tough Depression
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more medication.
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.
The Tab
1d
Should ketamine become a Class A drug? Tell us how you feel about its potential reclassification here
So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...
4d
on MSN
4 charged in major NYC ketamine drug trafficking bust dubbed ‘Operation Frostbite’
A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...
9d
on MSN
Research indicates recreational ketamine use is on the rise
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
US Weekly on MSN
12d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, More
Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
Medscape
7d
Ketamine-Induced Uropathy: What Urologists Need to Know
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
4d
Does Medicare cover ketamine infusions for mental health conditions?
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
5d
Randy Blythe Rips Elon Musk: He’s President Trump’s “Ketamine-Fueled Pet Rocket Monkey”
The Lamb of God frontman called the tech billionaire a "complete asshole." Randy Blythe Rips Elon Musk: He’s President ...
freedommag
17h
New Research Finds Dangerous Psychedelic Drugs Misrepresented by Psychiatry
With profit as the most obvious motive, psychiatry is pushing dangerous psychedelic drugs at every turn. New research studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Popular topics
# Ketamine
Related topics
Nasal spray
Food and Drug Administration
Johnson & Johnson
Feedback